
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
San Francisco - Phototherapy is effective for a host of skin conditions, but many dermatologists reserve it only for what it is best known for: psoriasis.






